title: Changes in dopamine receptor mRNA expression following chronic mild stress and chronic antidepressant treatment.
abstract: This study used in-situ hybridization to examine D1 and D2 receptor mRNA expression in the brains of rats subjected to chronic mild stress and/or chronic treatment (5 weeks) with the antidepressant drugs imipramine and fluoxetine. As in previous studies using the chronic mild stress procedure, stress decreased the consumption of a palatable sucrose solution, and both antidepressants reversed this effect. In-situ hybridization to D1 and D2 receptor probes was studied in midbrain and forebrain sections. In the midbrain sections, stress decreased the D2 receptor message in the substantia nigra and in the lateral part of the ventral tegmental area (VTA), but not in the medial part of the VTA. Imipramine, but not fluoxetine, increased the D2 receptor message in the VTA, but only in the non-stressed group. In the basal ganglia, stress decreased the D2 receptor message in the nucleus accumbens (core and shell) and in the lateral, but not the medial, part of the caudate nucleus, in both control and stressed groups. Both imipramine and fluoxetine increased the D2 receptor message in the lateral, but not the medial, part of the caudate nucleus and in the shell, but not the core, of the nucleus accumbens. There were no significant changes in D1 receptor message. The results, which are consistent in some respects, and inconsistent in others, with predictions from earlier work, support the hypothesis that forebrain dopamine systems are involved in mediating the behavioural effects of chronic mild stress and their reversal by antidepressants.
authors.affiliation: Institute of Pharmacology, Polish Academy of Sciences, Krakow, Poland.
authors.forename: M
authors.initials: M
authors.lastname: Dziedzicka-Wasylewska
authors.forename: P
authors.initials: P
authors.lastname: Willner
authors.forename: M
authors.initials: M
authors.lastname: Papp
mesh_terms: D000818:Animals; D000928:Antidepressive Agents / Q000494:pharmacology*; D001835:Body Weight / Q000187:drug effects; D019422:Dietary Sucrose / Q000494:pharmacology; D017403:In Situ Hybridization; D008297:Male; D008636:Mesencephalon / Q000187:drug effects / Q000378:metabolism; D017072:Neostriatum / Q000187:drug effects / Q000378:metabolism; D012333:RNA, Messenger / Q000096:biosynthesis*; D051381:Rats; D017208:Rats, Wistar; D011954:Receptors, Dopamine / Q000096:biosynthesis*; D017447:Receptors, Dopamine D1 / Q000096:biosynthesis; D017448:Receptors, Dopamine D2 / Q000096:biosynthesis; D013315:Stress, Psychological / Q000378:metabolism*
chemical_list: D000928:Antidepressive Agents; D019422:Dietary Sucrose; D012333:RNA, Messenger; D011954:Receptors, Dopamine; D017447:Receptors, Dopamine D1; D017448:Receptors, Dopamine D2